ATE339188T1 - Liposomenformulierung mit clobetasol propionate - Google Patents

Liposomenformulierung mit clobetasol propionate

Info

Publication number: ATE339188T1
Authority: AT; Austria
Prior art keywords: clobetasol propionate; active ingredient; liposome formulation; liposomes; psoriasis
Prior art date: 2000-07-17

Application number

AT01953764T

Other languages

English (en)

Inventor

Gutierrez Xiomara Perez

Leon Ladyth De La Carid Garcia

La Paz Martin-Viana Nilia De

Gonzalez Aymee Roche

Gonzalez Ignacio Hernandez

Diduk Natalia Albertovna

Cortada D Calle Linea E Granda

Original Assignee

Ct De Invest Y Desarrollo De M

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-17

Filing date

2001-07-17

Publication date

2006-10-15

2001-07-17 Application filed by Ct De Invest Y Desarrollo De M filed Critical Ct De Invest Y Desarrollo De M

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE339188T1 publication Critical patent/ATE339188T1/de

Links

229960004703 clobetasol propionate Drugs 0.000 title abstract 3
CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 title abstract 3
239000002502 liposome Substances 0.000 title abstract 3
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
206010012438 Dermatitis atopic Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
201000008937 atopic dermatitis Diseases 0.000 abstract 1
230000002349 favourable effect Effects 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Immunology (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01953764T 2000-07-17 2001-07-17 Liposomenformulierung mit clobetasol propionate ATE339188T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CU20000171A CU23175A1 (es)	2000-07-17	2000-07-17	Formulacion liposomica de propionato de clobetasol

Publications (1)

Publication Number	Publication Date
ATE339188T1 true ATE339188T1 (de)	2006-10-15

Family

ID=40134847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01953764T ATE339188T1 (de)	2000-07-17	2001-07-17	Liposomenformulierung mit clobetasol propionate

Country Status (12)

Country	Link
EP (1)	EP1360958B1 (de)
CN (1)	CN100346773C (de)
AT (1)	ATE339188T1 (de)
AU (2)	AU2001276254B2 (de)
BR (1)	BR0112553A (de)
CA (1)	CA2416731C (de)
CU (1)	CU23175A1 (de)
DE (1)	DE60123132T2 (de)
DK (1)	DK1360958T3 (de)
ES (1)	ES2272508T3 (de)
MX (1)	MXPA03000207A (de)
WO (1)	WO2002007702A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7291626B1 (en)	1998-04-09	2007-11-06	John Hopkins University School Of Medicine	Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
CA2386190C (en)	1999-10-13	2009-04-14	Johns Hopkins University School Of Medicine	Regulators of the hedgehog pathway, compositions and uses related thereto
ES2250434T3 (es) *	2001-07-02	2006-04-16	Tas, Sinan	Utilizacion de ciclopamina en el tratamiento del carcinoma de celulas basales y de otros tumores.
CA2452152A1 (en)	2001-07-02	2002-10-10	Sinan Tas	Use of cyclopamine in the treatment of psoriasis
WO2017037663A1 (en)	2015-09-02	2017-03-09	Cadila Healthcare Limited	Topical compositions comprising corticosteroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1523965A (en) *	1976-03-19	1978-09-06	Ici Ltd	Pharmaceutical compositions containing steroids
US5192528A (en) *	1985-05-22	1993-03-09	Liposome Technology, Inc.	Corticosteroid inhalation treatment method
CA2129828A1 (en) *	1992-02-12	1993-08-19	Giovanni Lucchetti	Liposomal itraconazole formulations

2000
- 2000-07-17 CU CU20000171A patent/CU23175A1/es not_active IP Right Cessation
2001
- 2001-07-17 DK DK01953764T patent/DK1360958T3/da active
- 2001-07-17 CN CNB018128955A patent/CN100346773C/zh not_active Expired - Fee Related
- 2001-07-17 AU AU2001276254A patent/AU2001276254B2/en not_active Ceased
- 2001-07-17 BR BR0112553-2A patent/BR0112553A/pt not_active Application Discontinuation
- 2001-07-17 AU AU7625401A patent/AU7625401A/xx active Pending
- 2001-07-17 DE DE60123132T patent/DE60123132T2/de not_active Expired - Lifetime
- 2001-07-17 MX MXPA03000207A patent/MXPA03000207A/es active IP Right Grant
- 2001-07-17 ES ES01953764T patent/ES2272508T3/es not_active Expired - Lifetime
- 2001-07-17 WO PCT/CU2001/000005 patent/WO2002007702A2/es not_active Ceased
- 2001-07-17 CA CA002416731A patent/CA2416731C/en not_active Expired - Fee Related
- 2001-07-17 AT AT01953764T patent/ATE339188T1/de active
- 2001-07-17 EP EP01953764A patent/EP1360958B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2272508T3 (es)	2007-05-01
DE60123132D1 (de)	2006-10-26
CN1547465A (zh)	2004-11-17
AU2001276254B2 (en)	2006-07-13
EP1360958A2 (de)	2003-11-12
AU7625401A (en)	2002-02-05
CU23175A1 (es)	2006-09-22
EP1360958B1 (de)	2006-09-13
DK1360958T3 (da)	2007-01-29
BR0112553A (pt)	2003-06-24
WO2002007702A3 (es)	2003-07-31
CA2416731C (en)	2009-12-15
CN100346773C (zh)	2007-11-07
WO2002007702A2 (es)	2002-01-31
MXPA03000207A (es)	2004-09-13
HK1071070A1 (zh)	2005-07-08
DE60123132T2 (de)	2007-04-12
CA2416731A1 (en)	2003-01-16

Similar Documents

Publication	Publication Date	Title
US20240115707A1 (en)	2024-04-11	Dna repair composition
Schmid et al.	1996	Therapeutic progress with topical liposome drugs for skin disease
JP2947668B2 (ja)	1999-09-13	固体脂質粒子の懸濁液を含有する局所製剤
AU743528B2 (en)	2002-01-31	Cosmetic compositions
EP1138323A3 (de)	2001-10-24	Resveratrol zur Behandlung von schuppendem Ekzem, Akne oder Psoriasis
ATE237311T1 (de)	2003-05-15	Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
CA1261757A (en)	1989-09-26	Compositions for treating acne vulgaris and methods of making and using same
ES2599973T3 (es)	2017-02-06	Una formulación tópica de propionato de clobetasol de nivel bajo para tratar trastornos de la membrana mucosa y de la piel
CA2175472A1 (en)	1995-05-18	Propylene glycol stearate vesicles
US6228891B1 (en)	2001-05-08	Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
CA2196780A1 (en)	1996-02-15	A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents
WO2002076427A3 (en)	2003-05-08	Ph sensitive liposomal drug delivery
JP2007508243A (ja)	2007-04-05	両親媒性コポリマーゲル化剤を含む泡坦体
Mezei	2017	Liposomes and the skin
NO992638L (no)	1999-07-16	Gelformulering for topisk legemiddellevering
NO962972D0 (no)	1996-07-16	Preparat for perkutan absorpsjon
JP2012511515A (ja)	2012-05-24	局所的な施用のための組成物および方法
US20060088497A1 (en)	2006-04-27	Topical skin care composition
JP2005507882A (ja)	2005-03-24	皮膚不調の治療方法
ATE339188T1 (de)	2006-10-15	Liposomenformulierung mit clobetasol propionate
Korting et al.	1991	Topical liposome drugs to come: what the patent literature tells us: a review
WO2001041706A2 (en)	2001-06-14	Lipid nanotubules for topical delivery
JPH04338319A (ja)	1992-11-25	養毛化粧料
ATE179070T1 (de)	1999-05-15	Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
EP0815842A3 (de)	1998-01-28	Arzneimittel und Kosmetika enthaltend Zizyphus-spina-christi Extrakte

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1360958

Country of ref document: EP